The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCap-xx Regulatory News (CPX)

Share Price Information for Cap-xx (CPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.078
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.004 (5.263%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.078
CPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Spire Health Selects CAP-XX Supercapacitors

7 Sep 2021 07:00

RNS Number : 8639K
CAP-XX Limited
07 September 2021
 

REACH

 

7 September 2021

 

CAP-XX Limited

 

("CAP-XX")

 

CAP-XX Supercaps Power Spire Health's Remote Respiratory Monitoring for Patients with Chronic Respiratory Diseases

 

Supercapacitors handle peak power role to keep Spire Health Tag's battery small and form factor thin

 

Sydney, Australia - September 7, 2021 - CAP-XX Limited (LSE:CPX), the leading manufacturer of ultra-thin prismatic and cylindrical supercapacitors, announced that Spire Health, the leading provider of respiratory remote patient monitoring (RPM), has selected the CAP-XX supercap to provide the peak power needed to deliver respiratory and pulse rate monitoring for pulmonary patients in the company's new Health Tag garment-adhered sensor. The company's original Health Tags used CAP-XX supercapacitors to deliver wellness alerts to consumers. The new Health Tag's core focus is now healthcare, where the CAP-XX supercapacitors are used to notify a patient's care team of changes in their health in an effort to enable early interventions and prevent hospital admissions.

 

Offloading the peak power role to the thin, flat supercapacitor allows Spire to keep the battery small to achieve the ultra-thin form factor of its wearable biosensor. The tag's 3V coin cell battery continuously trickle charges the CAP-XX HA114T supercapacitor (0.7mm thin, 120 millifarads, 130 milli-Ohms), which then provides the pulses of 660mW to power LED pulse rate notifications.

 

Spire Health Tags adhere to a patient's existing clothing, can be washed and dried as normal, need no charging and last up to 12 months. The Health Tags use advanced algorithms and proprietary respiratory sensors to continuously measure, with medical grade accuracy, a patient's respiratory effort, pulse rate and activity. This data is displayed on the patient's mobile app. Deviations from clinical baselines are automatically detected and shared with the patient's care team through the healthcare professional dashboard. Changes in patient health are often detected many days before a patient reports symptoms or experiences physiological decline.

 

The CAP-XX HA114T supercapacitor's features include:

· 120 mF / 2.75 Volt

· 20 x 20 x 0.7 mm

· Very low Equivalent Series Resistance (ESR) of 130 mΩ

· Up to 10 year life

 

"Spire Health Tags are the only commercial solution for remote long term, continuous monitoring of respiratory effort," said Phil Golz, Vice President, Spire Health. "The 100% passive sensor requires no interaction or engagement from patients, and research has shown that our algorithms can detect subtle changes in respiratory patterns days before patients are hospitalized due to acute exacerbations. This is tremendously exciting for the future of care for patients living with chronic respiratory conditions."

 

"CAP-XX's thin, prismatic supercaps address the size, weight and cost challenges of designing thin, sometimes disposable electronic IoT devices like wearables and portables," said Alex Bilyk, VP, Research and Development at CAP-XX. "They help IoT device manufacturers add peak-power features, extend battery life, avoid oversized batteries, or even replace batteries when paired with an energy harvester."

 

 

For further information contact:

CAP-XX Limited

Anthony Kongats (CEO)

 

+61 (0) 2 9428 0139

Kreab (Financial PR)

Robert Speed

 

+44 (0) 20 7074 1800

Allenby Capital (Nominated Adviser and Joint Broker)

David Hart / Alex Brearley (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

 

+44 (0) 20 3328 5656

Cenkos Securities plc (Joint Broker)

Neil McDonald / Pete Lynch

 

+44 (0) 13 1220 6939

 

About CAP-XX

CAP-XX (LSE:CPX) is a world leader in the design and manufacture of ultra-thin prismatic and compact cylindrical supercapacitors. Its prismatic supercapacitors are manufactured in Australia and Malaysia and its cylindrical supercapacitors are manufactured in China. The company's strong intellectual property (IP) portfolio includes 21 patents worldwide. CAP-XX's ultra-thin prismatic supercapacitors are ideal for space-constrained electronics applications where small energy storage device size and thickness are important. The unique feature of CAP-XX supercapacitors is their very high-power density and high-energy storage capacity in space-efficient thin prismatic and compact cylindrical packages. For more information about CAP-XX, visit https://www.cap-xx.com/ or email sales@cap-xx.com.

 

About Spire Health

Spire Health is the leading digital healthcare company for continuous respiratory monitoring and actionable feedback. The Spire Health Tag enables remote patient monitoring with unparalleled adherence and clinical-grade accuracy. Spire Health's remote patient monitoring approach has the potential to identify and predict health events, enable early interventions, and prevent hospital admissions. Spire is backed by leading medical health investors and has received a grant from the US Department of Health and Human Services. For more information visit: www.spirehealth.com.

 

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFZGGLMVDGMZM
Date   Source Headline
14th Oct 201312:40 pmRNSGranting of Share Options
3rd Oct 20133:32 pmRNSNotice of AGM and Posting of Report & Accounts
1st Oct 20137:00 amRNSResults for the year ended 30 June 2013
12th Sep 20139:32 amRNSMurata launches new supercapacitor
29th Aug 20131:11 pmRNSResult of General Meeting
22nd Jul 20131:00 pmRNSProposed Placing and Notice of General Meeting
6th Jun 20137:00 amRNSEncouraging customer orders
14th May 20137:00 amRNSLaunch of large prismatic supercapacitors
11th Apr 201310:33 amRNSChange of Adviser
3rd Apr 20137:00 amRNSPositive in-vehicle Supercapacitor Test Results
5th Mar 20137:00 amRNSInterim Results
11th Dec 20128:33 amRNSDirectorate Change
6th Nov 20129:55 amRNSResult of AGM
11th Oct 20129:12 amRNSNotice of AGM & Posting of Report & Accounts
9th Oct 20127:00 amRNSAudited Results for the year ended 30 June 2012
4th Oct 201212:30 pmRNSUpdate & Notice of Results
24th Aug 20127:00 amRNSAppointment of Non-executive Director
3rd Aug 20127:00 amRNSTrading & Placing Update
5th Jul 20125:27 pmRNSBoard Change
30th May 20129:00 amRNSPlacing Update
2nd May 201211:00 amRNSDirector/PDMR Shareholding
26th Apr 20129:24 amRNSDirector/PDMR Shareholding
23rd Apr 20127:00 amRNSCold Weather Automotive Applications
2nd Apr 20124:39 pmRNSHolding(s) in Company
30th Mar 20128:08 amRNSTotal Voting Rights and Placing Update
29th Mar 20121:45 pmRNSHolding in Company & Director Interest
19th Mar 201212:12 pmRNSHolding(s) in Company
12th Mar 20129:30 amRNSIssue of Equity
27th Feb 20127:00 amRNSHalf Yearly Report
27th Feb 20127:00 amRNSAutomotive Stop-Start commercialisation agreement
17th Feb 20129:56 amRNSHolding(s) in Company
14th Feb 20127:00 amRNSCAP-XX develops Automotive Supercapacitor
3rd Feb 20124:18 pmRNSHolding(s) in Company
23rd Dec 20119:27 amRNSGranting of Share Options
21st Dec 20111:00 pmRNSForm 8.3 - CAP-XX Limited
19th Dec 20117:00 amRNSGrant award and receipt of tax credit
8th Dec 20117:00 amRNSFinal Murata payment received
23rd Nov 201110:55 amRNSResult of AGM
23rd Nov 20117:00 amRNSAGM Statement
31st Oct 20118:53 amRNSHolding(s) in Company
24th Oct 201112:08 pmRNSHolding(s) in Company
21st Oct 201111:00 amRNSNotice of AGM and Posting of Report & Accounts
20th Oct 20117:00 amRNSMurata confirms supercapacitor launch
17th Oct 20117:00 amRNSFinal Results
12th Aug 20117:00 amRNSAppointment of Non Exec Director
27th Jun 20117:00 amRNSReceipt of royalty payment and trading update
2nd Jun 20115:43 pmRNSTR-1
24th May 20117:00 amRNSPlacing and Trading Update
16th Mar 20117:00 amRNSMurata Update
7th Mar 20117:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.